# United Kingdom Digital Health Market --- ## Market Overview # CHAPTER 1 - Market Overview The United Kingdom Digital Health Market connects electronic patient records, virtual consultations, remote monitoring, analytics, clinical decision support and patient-engagement platforms with NHS, social care and independent-provider workflows. More than **39 million people were registered for the NHS App in 2025**, while 67.8 million repeat prescriptions were ordered through it during the twelve months ending November 2025, creating a large addressable transaction base for integrated solutions. London and South East England form the principal commercial and innovation cluster, supported by NHS headquarters functions, major academic health science centres, specialist investors and the headquarters of six companies profiled in this report. The region accounted for an estimated **37% of national digital health revenue in 2025**, although procurement remains distributed across integrated care systems, hospital trusts, primary care networks and devolved health administrations. Regulation materially affects development cost, clinical validation, market access and post-market surveillance. Software and AI intended for a medical purpose can fall within the UK Medical Devices Regulations 2002. The 2025 regulatory reform programme examined additional routes to market and international recognition, requiring suppliers to differentiate general wellness software from regulated clinical products before establishing pricing, evidence and deployment strategies. The market is moving from isolated digitisation projects toward system-wide workflow redesign, prevention and data-enabled care. Spending Review 2025 committed up to **USD 12,700 Mn equivalent for NHS technology and digital transformation by 2028-29**, based on the report's locked currency-conversion convention. The programme supports a policy objective of approximately 2% annual NHS productivity improvement, increasing demand for solutions with measurable operational outcomes. ## KPIs at a Glance * Market Value: USD 14,850 Mn (2025) * Dominant Region: London and South East (2025) * Dominant Segment: AI and Machine Learning (fastest growing) * Total Number of Players: 1,600 ## Future Outlook The United Kingdom Digital Health Market is projected to expand from USD 14,850 Mn in 2025 to **USD 35,430 Mn by 2031**. This implies a forecast CAGR of 15.6%, above the 14.0% historical CAGR recorded between 2020 and 2025. Expansion will be driven by NHS technology investment, completion of electronic patient record programmes, wider use of virtual wards, automated administration, AI-enabled diagnostics and digital pathways that shift appropriate activity from hospitals into primary, community and home-based care. Growth will increasingly depend on workflow integration rather than standalone application adoption. Cloud platforms, interoperable records, remote monitoring and clinical AI are expected to capture a larger revenue mix as buyers prioritise productivity, waiting-list management and continuity of care. Value growth is projected to exceed deployment-volume growth by approximately 3 percentage points annually during most of the forecast period, reflecting higher cybersecurity, integration, regulatory-evidence and managed-service requirements. Vendors able to demonstrate clinical safety, NHS interoperability and repeatable procurement outcomes will hold the strongest commercial position. --- | | | | --- | --- | | **15.6%** Forecast CAGR | **USD 35,430 Mn** 2031 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020-2025** | Forecast Period **2026-2031** | Historical CAGR **14.0%** | --- --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** United Kingdom * **Historical Period:** 2020-2025 * **Base Year:** 2025 * **Forecast Period:** 2026-2031 * **Market Segments Covered:** 7 primary segmentation dimensions (Solution Type, Care Setting, End User, Disease Area, Channel, Technology, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn/Bn ### Segmentation Data Tree * Solution Type + Electronic Health Records and Interoperability - Primary and community care records - Acute and shared care records + Telehealth and Virtual Care - Scheduled virtual consultations - Digital triage and urgent care + Remote Monitoring and Digital Therapeutics - Connected physiological monitoring - Software-based therapeutic programmes + Healthcare Analytics and Clinical AI - Clinical decision support - Operational and population analytics * Care Setting + Hospitals and Acute Care - Inpatient and emergency workflows - Diagnostics and elective pathways + Primary and Community Care - General practice and pharmacy - Community and mental health services + Home and Virtual Care - Virtual wards and hospital at home - Long-term condition monitoring + Social Care and Care Homes - Residential and nursing care - Domiciliary and supported living care * End User + NHS Providers - NHS trusts and integrated care systems - Primary care networks and practices + Independent Healthcare Providers - Private hospitals and clinics - Independent diagnostics and pharmacies + Social Care Providers - Local authority commissioned providers - Independent care organisations + Employers Payers and Consumers - Employer-funded digital health services - Consumer subscriptions and self-pay users * Disease Area + General and Multispecialty Care - General medicine and primary care - Urgent and elective care coordination + Chronic and Cardiometabolic Care - Diabetes and obesity management - Cardiovascular and respiratory monitoring + Mental and Behavioral Health - Digital psychological therapies - Remote assessment and crisis support + Oncology Diagnostics and Specialty Care - Cancer diagnostics and navigation - Neurology and specialty pathways * Channel + Public Procurement and Frameworks - National and regional frameworks - Trust and integrated care procurement + Direct Enterprise Sales - Provider software contracts - Life-sciences and research contracts + Insurance and Employer Channels - Insurer-funded virtual healthcare - Employee health and wellbeing platforms + Consumer App Stores and Subscriptions - Direct-to-consumer subscriptions - Freemium and in-app purchases * Technology + Cloud and SaaS Platforms - Public and sovereign cloud hosting - Subscription-based clinical applications + AI and Machine Learning - Predictive and generative AI - Computer vision and natural language processing + Connected Devices and IoT - Medical-grade monitoring devices - Consumer wearables and sensors + Mobile and Web Applications - Patient-facing mobile applications - Clinician portals and web applications * Geography + London and South East - Greater London - South East England + Midlands and East of England - East and West Midlands - East of England + North of England - North West and Yorkshire - North East England + Scotland Wales and Northern Ireland - Scotland and Wales - Northern Ireland --- --- ## Market Trajectory # Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyses year-over-year growth dynamics and presents forecast projections supported by market performance indicators, digital adoption, institutional investment and demand-side drivers. ### Historical and Projected Market Size | Year | Market Size (USD Mn) | Status | | --- | --- | --- | | 2020 | 7,700 | Historical | | 2021 | 9,100 | Historical | | 2022 | 10,500 | Historical | | 2023 | 11,900 | Historical | | 2024 | 13,300 | Historical | | 2025 | 14,850 | Base Year | | 2026F | 17,300 | Forecast | | 2027F | 20,100 | Forecast | | 2028F | 23,250 | Forecast | | 2029F | 26,850 | Forecast | | 2030F | 30,850 | Forecast | | 2031F | 35,430 | Forecast | ### YoY Growth Rate | Year | YoY Growth Rate (%) | | --- | --- | | 2021 | 18.2% | | 2022 | 15.4% | | 2023 | 13.3% | | 2024 | 11.8% | | 2025 | 11.7% | | 2026F | 16.5% | | 2027F | 16.2% | | 2028F | 15.7% | | 2029F | 15.5% | | 2030F | 14.9% | | 2031F | 14.8% | ### Market Value vs Volume Growth | Year | Deployment Volume Index | Market Value Growth (%) | Deployment Volume Growth (%) | Price and Mix Growth (%) | | --- | --- | --- | --- | --- | | 2020 | 100 | Base | Base | Base | | 2021 | 115 | 18.2% | 15.0% | 2.8% | | 2022 | 130 | 15.4% | 13.0% | 2.1% | | 2023 | 145 | 13.3% | 11.5% | 1.6% | | 2024 | 162 | 11.8% | 11.7% | 0.0% | | 2025 | 181 | 11.7% | 11.7% | -0.1% | | 2026F | 203 | 16.5% | 12.2% | 3.9% | | 2027F | 228 | 16.2% | 12.3% | 3.4% | | 2028F | 255 | 15.7% | 11.8% | 3.4% | | 2029F | 285 | 15.5% | 11.8% | 3.3% | | 2030F | 318 | 14.9% | 11.6% | 3.0% | ### Historical Market Performance Market expansion peaked at 18.2% in 2021 as remote consultation, digital triage and patient-access platforms moved rapidly into mainstream care. Growth moderated to 11.7% by 2025 as emergency pandemic deployments were replaced by structured procurement and integration programmes. Revenue became more concentrated in enterprise-grade records, interoperability, cloud hosting and managed clinical platforms. The estimated deployment-volume index increased from 100 in 2020 to 181 in 2025, showing that most historical value creation came from wider utilisation rather than sustained price inflation. ### Forecast Market Outlook The forecast CAGR of 15.6% is expected to lift the market to USD 35,430 Mn by 2031. Acceleration to 16.5% in 2026 reflects funded technology programmes, AI implementation and completion of digital infrastructure gaps. Growth then moderates toward 14.8% in 2031 as adoption matures. Deployment volume is projected to rise faster than 11% annually through 2030, while higher-value analytics, cybersecurity, integration and regulated software introduce a 3.0% to 3.9% annual price and mix contribution during the forecast period. --- --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The market breakdown integrates value, annual growth and three operating indicators that track patient-platform scale, virtual-care infrastructure and electronic patient-record adoption. | Year | Market Size (USD Mn) | YoY Growth (%) | NHS App Registered Users (Mn) | Virtual Ward Capacity (Beds) | NHS Trust EPR Adoption (%) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 7,700 | - | 2.0 | - | 55% | Historical | | 2021 | 9,100 | 18.2% | 22.0 | - | 64% | Historical | | 2022 | 10,500 | 15.4% | 30.0 | 7,000 | 73% | Historical | | 2023 | 11,900 | 13.3% | 33.6 | 10,000 | 86% | Historical | | 2024 | 13,300 | 11.8% | 35.0 | 12,500 | 90% | Historical | | 2025 | 14,850 | 11.7% | 39.0 | 13,500 | 92% | Base Year | | 2026F | 17,300 | 16.5% | 40.0 | 15,000 | 95% | Forecast and Latest Operating KPIs | | 2027F | 20,100 | 16.2% | 42.0 | 17,000 | 97% | Forecast and Industry Outlook | | 2028F | 23,250 | 15.7% | 44.0 | 19,000 | 98% | Forecast and Industry Outlook | | 2029F | 26,850 | 15.5% | 46.0 | 21,000 | 99% | Forecast and Industry Outlook | | 2030F | 30,850 | 14.9% | 48.0 | 23,000 | 100% | Forecast and Industry Outlook | | 2031F | 35,430 | 14.8% | 50.0 | 25,000 | 100% | Forecast and Industry Outlook | ### Operating KPI Deep Dives **KPI 1, NHS App Registered Users:** **39 million users, 2025, United Kingdom**. National patient-platform scale reduces distribution friction for appointment management, prescription ordering, health-record access and approved digital services. **KPI 2, NHS Trust EPR Adoption:** **92%, March 2025, England**. High basic adoption shifts procurement toward optimisation, data quality, interoperability, workflow redesign and advanced clinical functionality rather than first-time record installation. **KPI 3, Virtual Ward Capacity:** **10,000 beds, September 2023, England**. The national capacity milestone established a scalable pathway for hospital-at-home services, connected monitoring and remote clinical management. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework The segmentation framework identifies commercially measurable demand pools across solutions, care delivery, buyers, clinical applications, sales channels, enabling technologies and geographic clusters. ### Segmentation Summary | Dimension | Dominant Segment | 2025 Share | Fastest Growing Segment | Forecast CAGR | | --- | --- | --- | --- | --- | | Solution Type | Electronic Health Records and Interoperability | 32% | Healthcare Analytics and Clinical AI | 20.8% | | Care Setting | Hospitals and Acute Care | 45% | Home and Virtual Care | 19.1% | | End User | NHS Providers | 62% | Employers Payers and Consumers | 17.6% | | Disease Area | General and Multispecialty Care | 29% | Mental and Behavioral Health | 18.4% | | Channel | Public Procurement and Frameworks | 56% | Direct Enterprise Sales | 17.2% | | Technology | Cloud and SaaS Platforms | 46% | AI and Machine Learning | 22.3% | | Geography | London and South East | 37% | North of England | 16.8% | ### Detailed Segment Structure | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Solution Type | Electronic Health Records and Interoperability; Telehealth and Virtual Care; Remote Monitoring and Digital Therapeutics; Healthcare Analytics and Clinical AI | | 2 | Care Setting | Hospitals and Acute Care; Primary and Community Care; Home and Virtual Care; Social Care and Care Homes | | 3 | End User | NHS Providers; Independent Healthcare Providers; Social Care Providers; Employers Payers and Consumers | | 4 | Disease Area | General and Multispecialty Care; Chronic and Cardiometabolic Care; Mental and Behavioral Health; Oncology Diagnostics and Specialty Care | | 5 | Channel | Public Procurement and Frameworks; Direct Enterprise Sales; Insurance and Employer Channels; Consumer App Stores and Subscriptions | | 6 | Technology | Cloud and SaaS Platforms; AI and Machine Learning; Connected Devices and IoT; Mobile and Web Applications | | 7 | Geography | London and South East; Midlands and East of England; North of England; Scotland Wales and Northern Ireland | ### Solution Type Revenue Mix | Solution Type | 2025 Share | 2025 Revenue (USD Mn) | Forecast CAGR | | --- | --- | --- | --- | | Electronic Health Records and Interoperability | 32% | 4,752 | 12.9% | | Telehealth and Virtual Care | 25% | 3,713 | 15.8% | | Healthcare Analytics and Clinical AI | 23% | 3,416 | 20.8% | | Remote Monitoring and Digital Therapeutics | 20% | 2,970 | 18.7% | | **Total** | **100%** | **14,850** | **15.6%** | ### Key Segmentation Takeaways **Electronic Health Records and Interoperability** remains the largest solution category because primary, community, acute and social care organisations require persistent records, workflow tools and data exchange. Commercial growth is shifting from initial installation toward optimisation, cloud migration, decision support, medicines management and integration with patient-facing services. **AI and Machine Learning** is the fastest-growing technology segment as buyers test clinical documentation, diagnostic support, imaging analysis, capacity planning, population health and administrative automation. Sustainable adoption requires evidence of safety, transparent performance, integration into clinical workflows and a defined accountability model for human oversight. Public procurement remains the largest route to market, but direct enterprise, insurer, employer and consumer channels reduce dependence on long NHS sales cycles. Vendors increasingly combine national framework eligibility with targeted partnerships, outcome evidence and implementation capacity at trust, integrated care system and provider-group level. --- --- ## Regional Analysis # Regional Analysis The United Kingdom ranks among Europe's three largest national digital health markets under a harmonised revenue scope. Its scale reflects centralised health-system purchasing, high patient-platform adoption, advanced research institutions and a national policy commitment to move care from analogue to digital channels. ### KPI Summary * United Kingdom Ranking: **3rd** * United Kingdom Market Size: **USD 14,850 Mn** * United Kingdom CAGR: **15.6%** | Country | Market Size (USD Mn, 2025) | CAGR (2026-2031) | Population Aged 65+ (%) | Digital Health Readiness Index (0-100) | | --- | --- | --- | --- | --- | | Germany | 21,300 | 14.2% | 23.2% | 82 | | France | 16,750 | 14.8% | 21.8% | 84 | | United Kingdom | 14,850 | 15.6% | 19.2% | 88 | | Netherlands | 6,550 | 13.7% | 20.5% | 90 | | Sweden | 4,750 | 12.9% | 20.8% | 91 | | Ireland | 2,450 | 16.1% | 15.0% | 83 | ### Market Position The United Kingdom ranks third in the selected European peer group, with national purchasing scale reinforced by more than **39 million NHS App registrations in 2025**. ### Growth Advantage The United Kingdom's **15.6% forecast CAGR** exceeds the modelled rates for Germany, France, the Netherlands and Sweden, supported by funded NHS transformation and AI adoption. ### Competitive Strengths National patient access, 92% trust EPR adoption and a planned **USD 12,700 Mn equivalent digital investment by 2028-29** create a comparatively deep deployment environment. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges and emerging opportunities across providers, platforms, infrastructure and patient segments. --- --- ## Growth Drivers ### Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the United Kingdom Digital Health Market, including growth catalysts, operational challenges and emerging opportunities across providers, platforms, infrastructure and patient segments. ## Growth Drivers ### Funded NHS Digital Transformation Public investment provides a durable demand anchor, with up to **USD 12,700 Mn equivalent committed by 2028-29** for NHS technology and digital transformation. * The commitment represents an almost **50% increase from 2025-26 spending levels**, expanding addressable budgets for infrastructure, records, AI, workflow tools and cybersecurity. * Digital investment supports a government objective of approximately **2% annual NHS productivity growth**, increasing scrutiny of implementation quality and measurable efficiency. * Suppliers with framework access, implementation capacity and quantified operational evidence can convert national policy into repeatable trust and integrated-care-system contracts. ### Scaled Patient Digital Engagement More than **39 million registered NHS App users in 2025** create a national channel for transactions, communication, records and pathway navigation. * Patients ordered **67.8 million repeat prescriptions during the twelve months ending November 2025**, demonstrating high-frequency use beyond one-time registration. * The app recorded **62.3 million logins in November 2025**, supporting integration opportunities for appointments, messaging, screening and personalised care plans. * Large-scale national access lowers distribution costs for approved services, although adoption value depends on accessible design, identity assurance and consistent provider integration. ### Shift Toward Home and Data-Enabled Care The NHS established **10,000 virtual ward beds by September 2023**, creating infrastructure for remote monitoring and hospital-at-home pathways. * Virtual ward reporting now covers capacity, occupancy and beds per 100,000 people across **153 lead providers**, enabling performance benchmarking and procurement planning. * Operational guidance targets occupancy consistently above **80%**, favouring integrated platforms that support referral, monitoring, escalation and discharge workflows. * Remote monitoring vendors benefit when solutions reduce avoidable admission risk while integrating with clinical records, command centres and community-service capacity. --- ## Market Challenges ### Fragmented Interoperability and Procurement Basic digitisation is widespread, but uneven integration remains material because hospital systems, primary care, community care and social care use different workflows and data structures. * Approximately **92% of NHS trusts had implemented EPR systems by March 2025**, shifting the problem from installation toward interoperability, optimisation and data quality. * Procurement decisions remain distributed across national bodies, trusts, integrated care systems, primary care organisations and devolved administrations, increasing sales and implementation complexity. * Commercial success requires standards-based APIs, migration services, implementation partners and evidence that solutions can function across existing supplier environments without creating additional workflow burden. ### Cybersecurity and Operational Resilience The UK experienced **204 nationally significant cyber incidents during the twelve months to August 2025**, more than double the prior-year figure. * Health was among the sectors reporting ransomware activity, making supplier security controls, incident response and service continuity core procurement criteria. * The 2024 Synnovis ransomware incident demonstrated that disruption to a connected diagnostic provider can affect multiple hospitals and wider clinical pathways. * Vendors must fund secure development, access management, monitoring, backup, recovery testing and supply-chain assurance, increasing operating costs but strengthening barriers to entry. ### Clinical Evidence and Regulatory Complexity AI and software intended for a medical purpose can be regulated under the **UK Medical Devices Regulations 2002**, requiring classification, evidence and post-market controls. * Regulated products require stronger clinical, technical and quality evidence than general wellness applications, increasing development time and specialist compliance expenditure. * Medical-device reform continued through **2025 and 2026**, creating transition requirements for routes to market, international recognition and post-market surveillance. * Suppliers need early regulatory scoping, clinical-safety management and evidence plans because late reclassification can materially disrupt product roadmaps and procurement commitments. --- ## Market Opportunities ### Clinical AI and Administrative Automation The 10 Year Health Plan seeks to make the NHS highly AI-enabled, creating demand for safe automation across clinical and administrative workflows. * **Monetizable angle:** Vendors can use enterprise subscriptions, managed services or outcome-linked contracts for documentation, diagnostics, coding, scheduling, triage and capacity optimisation. * **Who benefits:** NHS providers, clinicians, AI developers, cloud suppliers and implementation partners benefit when automation reduces repetitive work without weakening accountability. * **What must change:** Buyers require trusted datasets, independent evaluation, workflow redesign, monitoring, explainability and human-review controls before scaling high-impact clinical use cases. ### Integrated Remote Care for Chronic Conditions Virtual ward infrastructure and an ageing population create a recurring market for monitoring, escalation and digital therapeutic services outside hospitals. * **Monetizable angle:** Providers can combine platform subscriptions, connected devices, clinical monitoring and pathway services under multi-year contracts tied to defined patient cohorts. * **Who benefits:** Community providers, device manufacturers, virtual-care operators, hospitals and patients benefit from earlier intervention and more appropriate use of physical capacity. * **What must change:** Services need consistent referral criteria, sufficient clinical staffing, interoperable monitoring data, logistics support and occupancy discipline above the **80% operational benchmark**. ### Digitisation of Adult Social Care Adult social care public spending reached approximately **USD 35,300 Mn equivalent in 2024-25**, supporting a substantial adjacent market for care technology. * **Monetizable angle:** Digital care records, rostering, medicines management, remote monitoring and family communication can be sold through subscriptions and managed implementation services. * **Who benefits:** Care-home groups, domiciliary providers, local authorities, technology vendors and NHS discharge teams benefit from more accessible and consistent care information. * **What must change:** Adoption requires funding, workforce training, connectivity, cybersecurity and interoperability between social care records, primary care and hospital discharge systems. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview The market is moderately concentrated in core clinical records but fragmented across virtual care, monitoring, AI and engagement. NHS references, interoperability, clinical evidence, security and implementation capacity create substantial entry barriers. * **Key players:** 10 * **New Entrants (last 5 yrs):** - ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Optum EMIS | - | Leeds, United Kingdom | 1987 | Primary care records, pharmacy, interoperability and health analytics | | TPP | - | Leeds, United Kingdom | 1997 | SystmOne electronic records across primary, community and social care | | Oracle Corporation (Oracle Health) | - | Austin, United States | 1977 | Acute electronic health records, clinical workflows and health data platforms | | Epic Systems Corporation | - | Verona, United States | 1979 | Enterprise hospital records, patient portals and clinical interoperability | | System C Healthcare | - | Maidstone, United Kingdom | 1983 | Healthcare, social care, maternity and integrated care software | | Accurx | - | London, United Kingdom | 2016 | Patient communication, messaging, triage and care coordination | | Huma Therapeutics | - | London, United Kingdom | 2011 | Remote patient monitoring, digital companions and clinical trials | | Patients Know Best | - | Cambridge, United Kingdom | 2008 | Personal health records, patient access and integrated care data | | Doccla | - | London, United Kingdom | 2019 | Virtual wards, remote monitoring devices and clinical operations | | HealthHero | - | London, United Kingdom | 2020 | Virtual primary care, digital triage and employer health services | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * NHS Installed Site Coverage * Interoperability and Integration Breadth * UK Digital Health Revenue Growth * Adjusted EBITDA Margin ### Analysis Covered * **Market Share Analysis:** Estimates revenue concentration across records, virtual care and analytics * **Cross Comparison Matrix:** Benchmarks coverage, integration, growth and profitability across selected competitors * **SWOT Analysis:** Assesses company capabilities, vulnerabilities, opportunities and execution risks * **Pricing Strategy Analysis:** Compares subscriptions, implementation charges and managed-service commercial structures * **Company Profiles:** Summarises portfolios, footprints, capabilities and strategic market positioning --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage this market analysis for investment, strategy and operational planning. * **Investors:** CAGR, recurring revenue, procurement risk, scalability, exit pathways * **Corporates:** product positioning, partnerships, pricing, interoperability, market-entry strategy * **Government:** productivity, access, safety, cybersecurity, regional digital inclusion * **Operators:** utilisation, workflow impact, adoption, integration, clinical outcomes * **Financial institutions:** cash runway, contract visibility, concentration, covenant resilience ### What You'll Gain * Market sizing and trajectory * Policy and regulation mapping * Technology adoption indicators * Segment structure and levers * Competitive landscape shortlist * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Mapped national digital health programmes * Reviewed NHS adoption and activity * Assessed regulation and procurement frameworks * Tracked company portfolios and deployments #### Primary Research * Interviewed NHS chief information officers * Consulted digital health product directors * Engaged clinical safety and regulatory leads * Surveyed virtual-care operations managers #### Validation and Triangulation * Validated estimates across 304 respondents * Reconciled supplier and buyer spending * Cross-checked deployment and utilisation indicators * Stress-tested price and adoption assumptions ### Phase 2: Market Size Estimation #### Top-Down Assessment * National healthcare digital and technology expenditure * Revenue allocation across care settings and buyers * NHS investment and adoption data benchmarks #### Bottom-Up Modeling * Vendor revenues benchmarked by solution categories * Deployment volumes and annual contract values assessed * Installed systems multiplied by blended revenue #### Forecasting and Scenario Analysis * Regression linked funding, adoption and care activity * Scenarios included AI, regulation and procurement execution * Baseline, optimistic and constrained projections through 2031 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the full United Kingdom Digital Health Market value chain from software development and infrastructure through procurement, implementation, clinical operation and patient use. * Digital Platform and EHR Vendors * Virtual Care and Monitoring Providers * NHS and Independent Care Buyers * Data AI and Regulatory Specialists #### Sample Size A total of 304 respondents were engaged across market segments to establish robust commercial, operational, procurement and adoption coverage. * Digital Platform and EHR Vendors - 82 respondents (Chief Product Officers, Commercial Directors) * Virtual Care and Monitoring Providers - 74 respondents (Clinical Operations Directors, Programme Managers) * NHS and Independent Care Buyers - 86 respondents (Chief Information Officers, Procurement Directors) * Data AI and Regulatory Specialists - 62 respondents (Clinical Safety Officers, Regulatory Affairs Directors) #### Validation and Triangulation Validation compared supplier economics, buyer budgets, deployment activity, product utilisation and procurement evidence across respondent cohorts and value-chain positions. * Supplier revenues matched buyer budgets * Deployments reconciled with usage indicators * Pricing tested across procurement channels * Forecasts stress-tested under three scenarios --- --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: How large was the United Kingdom Digital Health Market in 2025? **A:** The United Kingdom Digital Health Market was estimated at USD 14,850 Mn in 2025. The scope includes electronic health records, interoperability, telehealth, virtual care, remote patient monitoring, digital therapeutics, patient-engagement applications, healthcare analytics and clinical AI. It excludes general-purpose IT equipment, telecommunications connectivity, non-health enterprise software and internally developed systems without identifiable external revenue. The estimate was triangulated through supplier revenue, operational deployments and demand-side healthcare technology expenditure. **Data used:** USD 14,850 Mn market value (2025); USD 13,300-16,500 Mn confidence range (2025) **So what:** Investors should assess solution-specific profit pools rather than treating digital health as a homogeneous technology category. #### Q: What growth is projected through 2031? **A:** The market is projected to reach USD 35,430 Mn by 2031, representing a 15.6% CAGR from the 2025 base year. Growth is expected to be strongest during 2026 and 2027 as funded NHS transformation, electronic-record optimisation, clinical AI and virtual-care programmes accelerate. Annual growth gradually moderates to 14.8% by 2031 as adoption matures. Analytics, AI, remote monitoring and higher-value managed services are expected to outgrow basic software installation. **Data used:** USD 35,430 Mn market value (2031); 15.6% forecast CAGR (2025-2031) **So what:** Strategy teams should prioritise categories where deployment growth and higher-value service mix reinforce one another. #### Q: Which digital health solution category is currently the largest? **A:** Electronic Health Records and Interoperability is the largest solution category, accounting for an estimated 32% of 2025 market revenue. Its position reflects widespread adoption across general practice, hospitals, community care, pharmacy and social care. Future spending will focus less on basic installation and more on integration, cloud migration, data quality, workflow redesign, shared records and decision support. Replacement barriers remain high because clinical systems hold critical longitudinal data and support daily operations. **Data used:** 32% solution share (2025); USD 4,752 Mn segment revenue (2025) **So what:** Entrants should complement established record systems through interoperable modules rather than relying on direct platform replacement. #### Q: Which segment is expected to grow fastest? **A:** AI and Machine Learning is projected to be the fastest-growing technology segment, with a 22.3% CAGR through 2031. Priority applications include clinical documentation, imaging analysis, diagnostic support, triage, demand forecasting, scheduling and population-risk identification. Commercial scaling will depend on reliable performance, workflow integration, clinical oversight and regulatory classification. Products that merely demonstrate technical capability without measurable provider value will face prolonged evaluation and weak procurement conversion. **Data used:** 22.3% AI and Machine Learning CAGR (2026-2031); 23% clinical AI and analytics solution share (2025) **So what:** Vendors should concentrate investment on narrow, high-value workflows supported by credible operational and clinical evidence. #### Q: What role does the NHS App play in market development? **A:** The NHS App provides a national patient-access layer that can reduce distribution friction for approved health services. More than 39 million people were registered by the end of 2025, and 67.8 million repeat prescriptions were ordered through the app during the preceding twelve months. Its scale supports appointments, messaging, records and pathway navigation. Commercial access is not automatic, because third-party functionality must meet integration, identity, safety, accessibility and information-governance requirements. **Data used:** 39 million registered users (2025); 67.8 million repeat prescription orders (12 months ending November 2025) **So what:** Product teams should design for NHS workflow and identity integration rather than treating the app as a conventional consumer marketplace. #### Q: What is the principal market-entry barrier? **A:** The principal barrier is not software development alone; it is demonstrating that a product can operate safely, securely and interoperably inside complex clinical workflows. Vendors must address clinical safety, data protection, cybersecurity, procurement, integration and implementation. AI and medical-purpose software can also require medical-device compliance. Long sales cycles and fragmented buyer authority increase cash requirements, while reference sites and framework eligibility materially influence subsequent contract awards. **Data used:** 92% NHS trust EPR adoption (March 2025); 204 nationally significant UK cyber incidents (12 months to August 2025) **So what:** Entrants need regulatory, clinical and implementation capabilities alongside product engineering and commercial sales. #### Q: Which business models are most attractive? **A:** Recurring enterprise subscriptions, managed services and pathway-based contracts offer the strongest revenue visibility when tied to critical provider workflows. Per-user pricing remains relevant for workforce tools, while per-patient or per-monitoring-episode structures suit virtual care and chronic-condition programmes. Outcome-linked pricing can differentiate vendors but requires agreed baselines and reliable measurement. Pure consumer subscriptions provide faster sales cycles but face acquisition costs, retention risk and limited reimbursement. **Data used:** 56% public procurement channel share (2025); 24% direct enterprise sales share (2025) **So what:** Providers should align pricing units with the operational value driver controlled by each buyer. --- --- ## Table of Contents # CHAPTER 14 - Table Of Contents ### Market Report Structure Comprehensive coverage across three strategic phases — Market Assessment, Go-To-Market Strategy, and Survey — delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. United Kingdom Digital Health Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 United Kingdom Digital Health Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. United Kingdom Digital Health Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Growth Drivers, Challenges & Opportunities ##### 3.1.2 Growth Drivers ##### 3.1.3 NHS Digital Transformation Funding Initiatives ##### 3.1.4 Rising Demand for Remote Patient Monitoring Solutions #### 3.2 Market Challenges ##### 3.2.1 Market Challenges ##### 3.2.2 Data Privacy and Cybersecurity Risks ##### 3.2.3 Fragmented NHS Procurement Processes ##### 3.2.4 Workforce Digital Skills Shortages #### 3.3 Market Opportunities ##### 3.3.1 Market Opportunities ##### 3.3.2 Expansion of Integrated Care Systems ##### 3.3.3 AI-Driven Clinical Decision Support Adoption ##### 3.3.4 Cross-Border Digital Health Partnerships #### 3.4 Market Trends ##### 3.4.1 Accelerated Adoption of Cloud-Based EHR Platforms ##### 3.4.2 Integration of Wearable Devices with NHS App Ecosystem ##### 3.4.3 Growth of Mental Health Digital Therapeutics ##### 3.4.4 Shift Toward Value-Based Care Reimbursement Models #### 3.5 Government Regulation ##### 3.5.1 UK GDPR Compliance for Health Data Processing ##### 3.5.2 MHRA Medical Device Software Regulations ##### 3.5.3 NHS Digital Technology Assessment Criteria ##### 3.5.4 Care Quality Commission Digital Standards Framework ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. United Kingdom Digital Health Market Market Size, 2019-2024 #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Selling Price ### 8. United Kingdom Digital Health Market Segmentation #### 8.1 Solution Type ##### 8.1.1 Electronic Health Records and Interoperability ##### 8.1.2 Telehealth and Virtual Care ##### 8.1.3 Remote Monitoring and Digital Therapeutics ##### 8.1.4 Healthcare Analytics and Clinical AI #### 8.2 Care Setting ##### 8.2.1 Hospitals and Acute Care ##### 8.2.2 Primary and Community Care ##### 8.2.3 Home and Virtual Care ##### 8.2.4 Social Care and Care Homes #### 8.3 End User ##### 8.3.1 NHS Providers ##### 8.3.2 Independent Healthcare Providers ##### 8.3.3 Social Care Providers ##### 8.3.4 Employers Payers and Consumers #### 8.4 Disease Area ##### 8.4.1 General and Multispecialty Care ##### 8.4.2 Chronic and Cardiometabolic Care ##### 8.4.3 Mental and Behavioral Health ##### 8.4.4 Oncology Diagnostics and Specialty Care #### 8.5 Channel ##### 8.5.1 Public Procurement and Frameworks ##### 8.5.2 Direct Enterprise Sales ##### 8.5.3 Insurance and Employer Channels ##### 8.5.4 Consumer App Stores and Subscriptions #### 8.6 Technology ##### 8.6.1 Cloud and SaaS Platforms ##### 8.6.2 AI and Machine Learning ##### 8.6.3 Connected Devices and IoT ##### 8.6.4 Mobile and Web Applications #### 8.7 Geography ##### 8.7.1 London and South East ##### 8.7.2 Midlands and East of England ##### 8.7.3 North of England ##### 8.7.4 Scotland Wales and Northern Ireland ### 9. United Kingdom Digital Health Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 NHS Installed Site Coverage ##### 9.2.4 Interoperability and Integration Breadth ##### 9.2.5 UK Digital Health Revenue Growth ##### 9.2.6 Adjusted EBITDA Margin ##### 9.2.7 Digital Maturity Score ##### 9.2.8 Patient Adoption Rate ##### 9.2.9 Clinical Outcome Improvement Metrics ##### 9.2.10 Partnership Network Strength #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Optum EMIS ##### 9.5.2 TPP ##### 9.5.3 Oracle Corporation (Oracle Health) ##### 9.5.4 Epic Systems Corporation ##### 9.5.5 System C Healthcare ##### 9.5.6 Accurx ##### 9.5.7 Huma Therapeutics ##### 9.5.8 Patients Know Best ##### 9.5.9 Doccla ##### 9.5.10 HealthHero ### 10. United Kingdom Digital Health Market End-User Analysis #### 10.1 Procurement Behavior of Key Ministries ##### 10.1.1 NHS England Framework Agreements ##### 10.1.2 Integrated Care Board Budget Cycles ##### 10.1.3 Public Tender Evaluation Criteria ##### 10.1.4 Multi-Year Digital Investment Planning #### 10.2 Corporate Spend on Infrastructure and Energy ##### 10.2.1 Cloud Hosting and Data Center Investments ##### 10.2.2 Cybersecurity Infrastructure Upgrades ##### 10.2.3 Device Procurement and Lifecycle Management ##### 10.2.4 Energy-Efficient Data Processing Solutions #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 Legacy System Integration Barriers ##### 10.3.2 Staff Training and Change Management Gaps ##### 10.3.3 Funding Allocation Delays ##### 10.3.4 Interoperability Across Care Settings #### 10.4 User Readiness for Adoption ##### 10.4.1 Digital Literacy Levels Among Clinicians ##### 10.4.2 Patient Engagement with Mobile Health Tools ##### 10.4.3 Trust in AI-Assisted Diagnostics ##### 10.4.4 Regional Infrastructure Readiness Variations #### 10.5 Post-Deployment ROI and Use Case Expansion ##### 10.5.1 Reduced Hospital Readmission Rates ##### 10.5.2 Operational Efficiency Gains in Primary Care ##### 10.5.3 Expanded Telehealth Service Offerings ##### 10.5.4 Data-Driven Population Health Improvements ### 11. United Kingdom Digital Health Market Future Size, 2025-2030 #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Selling Price ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 NHS Interoperability Gaps in Secondary Care #### 1.2 Subscription-Based Remote Monitoring Models #### 1.3 Regional Digital Health Equity Opportunities #### 1.4 Integrated Mental Health Platform Expansion ### 2. Marketing and Positioning Recommendations #### 2.1 NHS Trust Reference Site Development #### 2.2 Clinical Outcome-Focused Messaging #### 2.3 Regional Thought Leadership Campaigns #### 2.4 Patient-Centric Digital Trust Building ### 3. Distribution Plan #### 3.1 NHS Supply Chain Framework Leverage #### 3.2 Regional Integrated Care System Partnerships #### 3.3 Independent Provider Direct Sales Channels #### 3.4 Consumer App Store Optimization Strategy ### 4. Channel and Pricing Gaps #### 4.1 Public Sector Volume Discount Structures #### 4.2 Outcome-Based Pricing for Digital Therapeutics #### 4.3 SME Provider Affordability Barriers #### 4.4 Regional Pricing Differentiation Models ### 5. Unmet Demand and Latent Needs #### 5.1 Social Care Digital Integration Shortfalls #### 5.2 Oncology Remote Monitoring Solutions #### 5.3 Cross-Provider Data Sharing Platforms #### 5.4 Employer-Sponsored Preventive Health Tools ### 6. Customer Relationship #### 6.1 Dedicated NHS Account Management Teams #### 6.2 Clinical Champion Engagement Programs #### 6.3 Post-Sale Implementation Support Networks #### 6.4 User Community and Feedback Loops ### 7. Value Proposition #### 7.1 Reduced Administrative Burden for Clinicians #### 7.2 Improved Patient Access and Outcomes #### 7.3 Seamless NHS System Interoperability #### 7.4 Scalable Population Health Insights ### 8. Key Activities #### 8.1 Regulatory Compliance Certification Pursuit #### 8.2 Pilot Program Execution with NHS Trusts #### 8.3 Local Clinical Validation Studies #### 8.4 Strategic Partnership Development ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 NHS Innovation Accelerator Participation ##### 9.1.2 Regional Integrated Care Board Pilots ##### 9.1.3 Framework Agreement Tender Responses ##### 9.1.4 Clinical Reference Site Establishment #### 9.2 Export Entry Strategy ##### 9.2.1 Ireland NHS-Aligned Market Entry ##### 9.2.2 Netherlands Digital Health Partnerships ##### 9.2.3 Sweden Public Procurement Navigation ##### 9.2.4 France Regional Health Agency Engagement ### 10. Entry Mode Assessment #### 10.1 Joint Venture with UK Health Tech Firms #### 10.2 Direct Subsidiary Setup in London #### 10.3 Strategic Acquisition of Niche Players #### 10.4 Licensing Models for NHS Frameworks ### 11. Capital and Timeline Estimation #### 11.1 Initial Market Entry Investment Range #### 11.2 Regulatory Approval Timeline Projection #### 11.3 Pilot to Scale-Up Funding Milestones #### 11.4 Break-Even Analysis for UK Operations ### 12. Control vs Risk Trade-Off #### 12.1 Full Ownership Versus Partnership Balance #### 12.2 Data Governance and Compliance Risks #### 12.3 Intellectual Property Protection Strategies #### 12.4 Local Talent Acquisition Challenges ### 13. Profitability Outlook #### 13.1 Five-Year Revenue Growth Trajectory #### 13.2 Margin Improvement Through Scale #### 13.3 Recurring Revenue Stream Potential #### 13.4 Cost Optimization via Local Partnerships ### 14. Potential Partner List #### 14.1 NHS England Innovation Hubs #### 14.2 Academic Health Science Networks #### 14.3 Regional Integrated Care Systems #### 14.4 UK Health Tech Trade Associations ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Regulatory and Framework Approvals ##### 15.2.2 Initial NHS Trust Pilot Launches ##### 15.2.3 Regional Sales Team Expansion ##### 15.2.4 National Reference Site Development ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage — Priority Metros and Tier 2/3 Cities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1 — Large Enterprise End Users ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Metro Distribution #### 3.2 Cohort 2 — Mid-Size Enterprise End Users ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and City Distribution #### 3.3 Cohort 3 — Small and Emerging Enterprise End Users ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Tier 2/3 City Distribution #### 3.4 Cohort 4 — Institutional and Government End Users ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Compliance Drivers ##### 3.4.4 Represented Sample Size and Regional Distribution ### 4. Demand Attributes Analysis #### 4.1 Macroeconomic and Sectoral Growth Influences on Demand ##### 4.1.1 GDP and Industrial Output Linkages ##### 4.1.2 Urbanization and Infrastructure Expansion Impact ##### 4.1.3 Capital Investment Cycles and Procurement Timing ##### 4.1.4 Export and Import Dependency on United Kingdom Digital Health Market #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Purchases ##### 4.2.2 Seasonal and Cyclical Demand Variations ##### 4.2.3 Brand Loyalty vs. Price Sensitivity Trade-Off ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Cohorts ##### 4.3.2 Price Benchmarking Against Substitutes ##### 4.3.3 Regional Pricing Disparities ##### 4.3.4 Total Cost of Ownership Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Quality Standards and Certification Requirements ##### 4.4.2 Safety and Regulatory Compliance Awareness ##### 4.4.3 Perception of Domestic vs. Imported Offerings ##### 4.4.4 After-Sales Service and Support Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Regional Industry Clusters and Demand Hotspots ##### 4.5.2 Cultural and Operational Norms Influencing Procurement ##### 4.5.3 Peer Influence and Industry Association Impact ##### 4.5.4 Digital Adoption and E-Procurement Readiness #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Impact of Trade Shows, Exhibitions, and Industry Events ##### 4.6.2 Role of Digital Marketing and Online Platforms ##### 4.6.3 Distributor and Channel Partner Influence on Purchase ##### 4.6.4 OEM and System Integrator Partnership Impact ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Identified Gaps Between Current Supply and User Expectations #### 5.2 Latent Demand in Underpenetrated Segments #### 5.3 Willingness to Adopt New Formats or Technologies #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Product, Pricing, and Channel Strategy ### Disclaimer ### Contact Us